|
RBRC No. |
RBRC02346
|
|
Type |
Targeted Mutation |
 |
|
Species |
Mus musculus |
|
Strain name |
FVB.129P2-Epb4.113<tm3Gvn> |
|
Former Common name |
Dal1, Protein4.1B |
|
H-2 Haplotype |
No Data |
|
Background strain |
No Data |
|
Appearance |
| 1 |
Appearance |
No Data |
| Genotype |
No Data |
|
Strain description |
No Data |
|
Animal health report |
|
|
Gene Details |
|
Promoter |
No Data |
| 1 |
Symbol |
Epb4.1l3 |
| Symbol name |
erythrocyte protein band 4.1-like 3 |
| Chromosome |
17 |
| Common name |
4.1B, DAL1P, NBL3 |
| Symbol description |
No Data |
| 2 |
Symbol |
loxP |
| Symbol name |
phage P1 loxP |
| Chromosome |
17 |
| Common name |
No Data |
| Symbol description |
No Data |
|
References |
No Data |
|
Research applications |
Cre/loxP system |
|
Specific Term and Conditions |
The following terms and conditions will be requested by the DEPOSITOR.
In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested.
RECIPIENT shall keep DEPOSITOR apprised of any results obtained from the BIOLOGICAL RESOURCE in the course of the research, as soon as they are available. Moreover, if the research results in a potential invention or a substance that may have potential commercial value (hereinafter referred as to the "Invention") RECIPIENT will promptly disclose this Invention to DEPOSITOR with samples thereof for DEPOSITOR's internal use.
RECIPIENT and DEPOSITOR will consult together and agree about the possibility of filing one or more patent application to Invention conceived by one or more employees of Recipients that directly arise out of the research. The Parties will negotiate in good faith the conditions of such patent application according to each party's inventiveness contribution in the Invention.
In case of such Invention, patentable or not, reduced in practice or developed in the course of the research that could not have been obtained, reduced to practice or developed but from using the Material and/or Confidential Information, RECIPIENT and DEPOSITOR shall confer with one another as regards licensing and commercialization of such Invention to negotiate in good faith the terms of an institutional agreement as regards said matters. |
|
Additional information |
|
1 |
Contact Information |
|
2 |
Genotyping protocol <PCR> |
|
Depositor |
Giovannini, Marco (House Ear Institute)  |
|
Strain Status /
Availability
(Expected delivery) |
|
|
